Opinion
Video
Author(s):
William Sauve, MD shares the growing landscape of treatments for treatment resistant depression (TRD) and their mechanism of action, such as brain stimulation through electroconvulsive therapy or medication such as esketamine.
SPN-820 Fails Phase 2b Trial for Treatment-Resistant Depression
Medical Ethics Unpacked: GLP-1 Allocation and Challenges of Equitable Access
Antidepressant Use Drops During Pregnancy Without Psychotherapy Increase
Medical Ethics Unpacked: Ethical Considerations for Euthanasia & Medical Assistance in Dying
Researchers Track Sharp Increase in Diagnoses for Sedative, Hypnotic and Anxiety Use Disorder in Young Adults
Children Who Experience a Stroke Have a Greater Anxiety Risk